Managing ocular allergy in the time of COVID-19.
Identifieur interne : 000B35 ( Main/Exploration ); précédent : 000B34; suivant : 000B36Managing ocular allergy in the time of COVID-19.
Auteurs : Andrea Leonardi [Italie] ; Jean L. Fauquert [France] ; Serge Doan [France] ; Luis Delgado [Portugal] ; Nicolas Andant [France] ; Ludger Klimek [Allemagne] ; Banu Bozkurt [Turquie]Source :
- Allergy [ 1398-9995 ] ; 2020.
Descripteurs français
- KwdFr :
- Administration par voie ophtalmique (MeSH), Administration par voie orale (MeSH), Allergologues (MeSH), Antiallergiques (usage thérapeutique), Antihistaminiques (usage thérapeutique), Appréciation des risques (MeSH), Betacoronavirus (MeSH), Conjonctivite allergique (traitement médicamenteux), Guides de bonnes pratiques cliniques comme sujet (MeSH), Hormones corticosurrénaliennes (usage thérapeutique), Humains (MeSH), Infections à coronavirus (épidémiologie), Inhibiteurs de la calcineurine (usage thérapeutique), Ophtalmologistes (MeSH), Pandémies (MeSH), Pneumopathie virale (épidémiologie), Prise en charge de la maladie (MeSH), Saisons (MeSH), Types de pratiques des médecins (MeSH).
- MESH :
- traitement médicamenteux : Conjonctivite allergique.
- usage thérapeutique : Antiallergiques, Antihistaminiques, Hormones corticosurrénaliennes, Inhibiteurs de la calcineurine.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Administration par voie ophtalmique, Administration par voie orale, Allergologues, Appréciation des risques, Betacoronavirus, Guides de bonnes pratiques cliniques comme sujet, Humains, Ophtalmologistes, Pandémies, Prise en charge de la maladie, Saisons, Types de pratiques des médecins.
English descriptors
- KwdEn :
- Administration, Ophthalmic (MeSH), Administration, Oral (MeSH), Adrenal Cortex Hormones (therapeutic use), Allergists (MeSH), Anti-Allergic Agents (therapeutic use), Betacoronavirus (MeSH), Calcineurin Inhibitors (therapeutic use), Conjunctivitis, Allergic (drug therapy), Coronavirus Infections (epidemiology), Disease Management (MeSH), Histamine Antagonists (therapeutic use), Humans (MeSH), Ophthalmologists (MeSH), Pandemics (MeSH), Pneumonia, Viral (epidemiology), Practice Guidelines as Topic (MeSH), Practice Patterns, Physicians' (MeSH), Risk Assessment (MeSH), Seasons (MeSH).
- MESH :
- chemical , therapeutic use : Adrenal Cortex Hormones, Anti-Allergic Agents, Calcineurin Inhibitors, Histamine Antagonists.
- drug therapy : Conjunctivitis, Allergic.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- Administration, Ophthalmic, Administration, Oral, Allergists, Betacoronavirus, Disease Management, Humans, Ophthalmologists, Pandemics, Practice Guidelines as Topic, Practice Patterns, Physicians', Risk Assessment, Seasons.
DOI: 10.1111/all.14361
PubMed: 32402114
PubMed Central: PMC7273086
Affiliations:
- Allemagne, France, Italie, Portugal, Turquie
- Auvergne (région administrative), Auvergne-Rhône-Alpes, Île-de-France
- Clermont-Ferrand, Paris
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Managing ocular allergy in the time of COVID-19.</title><author><name sortKey="Leonardi, Andrea" sort="Leonardi, Andrea" uniqKey="Leonardi A" first="Andrea" last="Leonardi">Andrea Leonardi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua</wicri:regionArea><wicri:noRegion>Padua</wicri:noRegion></affiliation></author><author><name sortKey="Fauquert, Jean L" sort="Fauquert, Jean L" uniqKey="Fauquert J" first="Jean L" last="Fauquert">Jean L. Fauquert</name><affiliation wicri:level="3"><nlm:affiliation>Consultation Ophtalmologie et Allergie, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Consultation Ophtalmologie et Allergie, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Doan, Serge" sort="Doan, Serge" uniqKey="Doan S" first="Serge" last="Doan">Serge Doan</name><affiliation wicri:level="3"><nlm:affiliation>Service d'Ophtalmologie, Hôpital Bichat and Fondation A. de Rothschild, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'Ophtalmologie, Hôpital Bichat and Fondation A. de Rothschild, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Delgado, Luis" sort="Delgado, Luis" uniqKey="Delgado L" first="Luis" last="Delgado">Luis Delgado</name><affiliation wicri:level="1"><nlm:affiliation>Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, Serviço de Imunoalergologia, Centro Hospitalar São João, EPE, University of Porto, Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, Serviço de Imunoalergologia, Centro Hospitalar São João, EPE, University of Porto, Porto</wicri:regionArea><wicri:noRegion>Porto</wicri:noRegion></affiliation></author><author><name sortKey="Andant, Nicolas" sort="Andant, Nicolas" uniqKey="Andant N" first="Nicolas" last="Andant">Nicolas Andant</name><affiliation wicri:level="3"><nlm:affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Klimek, Ludger" sort="Klimek, Ludger" uniqKey="Klimek L" first="Ludger" last="Klimek">Ludger Klimek</name><affiliation wicri:level="1"><nlm:affiliation>Center for Rhinology and Allergology, Wiesbaden, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Rhinology and Allergology, Wiesbaden</wicri:regionArea><wicri:noRegion>Wiesbaden</wicri:noRegion><wicri:noRegion>Wiesbaden</wicri:noRegion><wicri:noRegion>Wiesbaden</wicri:noRegion></affiliation></author><author><name sortKey="Bozkurt, Banu" sort="Bozkurt, Banu" uniqKey="Bozkurt B" first="Banu" last="Bozkurt">Banu Bozkurt</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya</wicri:regionArea><wicri:noRegion>Konya</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32402114</idno><idno type="pmid">32402114</idno><idno type="doi">10.1111/all.14361</idno><idno type="pmc">PMC7273086</idno><idno type="wicri:Area/Main/Corpus">001331</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001331</idno><idno type="wicri:Area/Main/Curation">001331</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001331</idno><idno type="wicri:Area/Main/Exploration">001331</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Managing ocular allergy in the time of COVID-19.</title><author><name sortKey="Leonardi, Andrea" sort="Leonardi, Andrea" uniqKey="Leonardi A" first="Andrea" last="Leonardi">Andrea Leonardi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua</wicri:regionArea><wicri:noRegion>Padua</wicri:noRegion></affiliation></author><author><name sortKey="Fauquert, Jean L" sort="Fauquert, Jean L" uniqKey="Fauquert J" first="Jean L" last="Fauquert">Jean L. Fauquert</name><affiliation wicri:level="3"><nlm:affiliation>Consultation Ophtalmologie et Allergie, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Consultation Ophtalmologie et Allergie, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Doan, Serge" sort="Doan, Serge" uniqKey="Doan S" first="Serge" last="Doan">Serge Doan</name><affiliation wicri:level="3"><nlm:affiliation>Service d'Ophtalmologie, Hôpital Bichat and Fondation A. de Rothschild, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service d'Ophtalmologie, Hôpital Bichat and Fondation A. de Rothschild, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Delgado, Luis" sort="Delgado, Luis" uniqKey="Delgado L" first="Luis" last="Delgado">Luis Delgado</name><affiliation wicri:level="1"><nlm:affiliation>Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, Serviço de Imunoalergologia, Centro Hospitalar São João, EPE, University of Porto, Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, Serviço de Imunoalergologia, Centro Hospitalar São João, EPE, University of Porto, Porto</wicri:regionArea><wicri:noRegion>Porto</wicri:noRegion></affiliation></author><author><name sortKey="Andant, Nicolas" sort="Andant, Nicolas" uniqKey="Andant N" first="Nicolas" last="Andant">Nicolas Andant</name><affiliation wicri:level="3"><nlm:affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Klimek, Ludger" sort="Klimek, Ludger" uniqKey="Klimek L" first="Ludger" last="Klimek">Ludger Klimek</name><affiliation wicri:level="1"><nlm:affiliation>Center for Rhinology and Allergology, Wiesbaden, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Center for Rhinology and Allergology, Wiesbaden</wicri:regionArea><wicri:noRegion>Wiesbaden</wicri:noRegion><wicri:noRegion>Wiesbaden</wicri:noRegion><wicri:noRegion>Wiesbaden</wicri:noRegion></affiliation></author><author><name sortKey="Bozkurt, Banu" sort="Bozkurt, Banu" uniqKey="Bozkurt B" first="Banu" last="Bozkurt">Banu Bozkurt</name><affiliation wicri:level="1"><nlm:affiliation>Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey.</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya</wicri:regionArea><wicri:noRegion>Konya</wicri:noRegion></affiliation></author></analytic><series><title level="j">Allergy</title><idno type="eISSN">1398-9995</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Ophthalmic (MeSH)</term><term>Administration, Oral (MeSH)</term><term>Adrenal Cortex Hormones (therapeutic use)</term><term>Allergists (MeSH)</term><term>Anti-Allergic Agents (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>Calcineurin Inhibitors (therapeutic use)</term><term>Conjunctivitis, Allergic (drug therapy)</term><term>Coronavirus Infections (epidemiology)</term><term>Disease Management (MeSH)</term><term>Histamine Antagonists (therapeutic use)</term><term>Humans (MeSH)</term><term>Ophthalmologists (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (epidemiology)</term><term>Practice Guidelines as Topic (MeSH)</term><term>Practice Patterns, Physicians' (MeSH)</term><term>Risk Assessment (MeSH)</term><term>Seasons (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie ophtalmique (MeSH)</term><term>Administration par voie orale (MeSH)</term><term>Allergologues (MeSH)</term><term>Antiallergiques (usage thérapeutique)</term><term>Antihistaminiques (usage thérapeutique)</term><term>Appréciation des risques (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Conjonctivite allergique (traitement médicamenteux)</term><term>Guides de bonnes pratiques cliniques comme sujet (MeSH)</term><term>Hormones corticosurrénaliennes (usage thérapeutique)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (épidémiologie)</term><term>Inhibiteurs de la calcineurine (usage thérapeutique)</term><term>Ophtalmologistes (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (épidémiologie)</term><term>Prise en charge de la maladie (MeSH)</term><term>Saisons (MeSH)</term><term>Types de pratiques des médecins (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenal Cortex Hormones</term><term>Anti-Allergic Agents</term><term>Calcineurin Inhibitors</term><term>Histamine Antagonists</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Conjunctivitis, Allergic</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Conjonctivite allergique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiallergiques</term><term>Antihistaminiques</term><term>Hormones corticosurrénaliennes</term><term>Inhibiteurs de la calcineurine</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Ophthalmic</term><term>Administration, Oral</term><term>Allergists</term><term>Betacoronavirus</term><term>Disease Management</term><term>Humans</term><term>Ophthalmologists</term><term>Pandemics</term><term>Practice Guidelines as Topic</term><term>Practice Patterns, Physicians'</term><term>Risk Assessment</term><term>Seasons</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie ophtalmique</term><term>Administration par voie orale</term><term>Allergologues</term><term>Appréciation des risques</term><term>Betacoronavirus</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Ophtalmologistes</term><term>Pandémies</term><term>Prise en charge de la maladie</term><term>Saisons</term><term>Types de pratiques des médecins</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32402114</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1398-9995</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>09</Month></PubDate></JournalIssue><Title>Allergy</Title><ISOAbbreviation>Allergy</ISOAbbreviation></Journal><ArticleTitle>Managing ocular allergy in the time of COVID-19.</ArticleTitle><Pagination><MedlinePgn>2399-2402</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14361</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leonardi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7246-8580</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fauquert</LastName><ForeName>Jean L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Consultation Ophtalmologie et Allergie, CHU Montpied, Clermont-Ferrand, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doan</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Service d'Ophtalmologie, Hôpital Bichat and Fondation A. de Rothschild, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, Serviço de Imunoalergologia, Centro Hospitalar São João, EPE, University of Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andant</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Direction de l'Innovation et de la Recherche Clinique, CHU Montpied, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klimek</LastName><ForeName>Ludger</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Rhinology and Allergology, Wiesbaden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozkurt</LastName><ForeName>Banu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Faculty of Medicine, Selcuk University, Konya, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Allergy</MedlineTA><NlmUniqueID>7804028</NlmUniqueID><ISSNLinking>0105-4538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018926">Anti-Allergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D065095">Calcineurin Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006633">Histamine Antagonists</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060433" MajorTopicYN="N">Administration, Ophthalmic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072223" MajorTopicYN="Y">Allergists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018926" MajorTopicYN="N">Anti-Allergic Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065095" MajorTopicYN="N">Calcineurin Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003233" MajorTopicYN="N">Conjunctivitis, Allergic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006633" MajorTopicYN="N">Histamine Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072163" MajorTopicYN="Y">Ophthalmologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="Y">Practice Patterns, Physicians'</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>05</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32402114</ArticleId><ArticleId IdType="doi">10.1111/all.14361</ArticleId><ArticleId IdType="pmc">PMC7273086</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Leonardi A, Bogacka E, Fauquert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67(11):1327-1337.</Citation></Reference><Reference><Citation>Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;92(6):589-594.</Citation></Reference><Reference><Citation>Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020. https://doi.org/10.1016/j.ophtha.2020.03.026. [Epub ahead of print]</Citation></Reference><Reference><Citation>Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;2020-316304. https://doi.org/10.1136/bjophthalmol-2020-316304. [Epub ahead of print]</Citation></Reference><Reference><Citation>Leonardi A, Silva D, Perez Formigo D, et al. Management of ocular allergy. Allergy. 2019;74(9):1611-1630.</Citation></Reference><Reference><Citation>Leonardi A, Doan S, Amrane M, et al. A randomized, controlled trial of cyclosporine A Cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study. Ophthalmology. 2019;126(5):671-681.</Citation></Reference><Reference><Citation>Leonardi A, Busca F, Motterle L, et al. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol Scand. 2006;84(3):406-410.</Citation></Reference><Reference><Citation>Das AV, Donthineni PR, Sai Prashanthi G, Basu S. Allergic eye disease in children and adolescents seeking eye care in India: electronic medical records driven big data analytics report II. Ocul Surf. 2019;17(4):683-689.</Citation></Reference><Reference><Citation>Alemayehu AM, Yibekal BT, Fekadu SA. Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018. PLoS One. 2019;14(4):e0215528.</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>France</li><li>Italie</li><li>Portugal</li><li>Turquie</li></country><region><li>Auvergne (région administrative)</li><li>Auvergne-Rhône-Alpes</li><li>Île-de-France</li></region><settlement><li>Clermont-Ferrand</li><li>Paris</li></settlement></list><tree><country name="Italie"><noRegion><name sortKey="Leonardi, Andrea" sort="Leonardi, Andrea" uniqKey="Leonardi A" first="Andrea" last="Leonardi">Andrea Leonardi</name></noRegion></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Fauquert, Jean L" sort="Fauquert, Jean L" uniqKey="Fauquert J" first="Jean L" last="Fauquert">Jean L. Fauquert</name></region><name sortKey="Andant, Nicolas" sort="Andant, Nicolas" uniqKey="Andant N" first="Nicolas" last="Andant">Nicolas Andant</name><name sortKey="Doan, Serge" sort="Doan, Serge" uniqKey="Doan S" first="Serge" last="Doan">Serge Doan</name><name sortKey="Fauquert, Jean L" sort="Fauquert, Jean L" uniqKey="Fauquert J" first="Jean L" last="Fauquert">Jean L. Fauquert</name></country><country name="Portugal"><noRegion><name sortKey="Delgado, Luis" sort="Delgado, Luis" uniqKey="Delgado L" first="Luis" last="Delgado">Luis Delgado</name></noRegion></country><country name="Allemagne"><noRegion><name sortKey="Klimek, Ludger" sort="Klimek, Ludger" uniqKey="Klimek L" first="Ludger" last="Klimek">Ludger Klimek</name></noRegion></country><country name="Turquie"><noRegion><name sortKey="Bozkurt, Banu" sort="Bozkurt, Banu" uniqKey="Bozkurt B" first="Banu" last="Bozkurt">Banu Bozkurt</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B35 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B35 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32402114
|texte= Managing ocular allergy in the time of COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32402114" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |